Boryung Pharmaceutical Co. Ltd. | Ownership
Companies that own Boryung Pharmaceutical Co. Ltd.
National Pension Service of Korea
1,771,410
4.01%
-359,270
0.01%
03/15/2017
Mirae Asset Global Investments Co., Ltd.
708,576
1.6%
546,406
0.06%
04/30/2018
Dimensional Fund Advisors LP
388,910
0.88%
6,340
0%
04/30/2018
Norges Bank Investment Management
242,900
0.55%
-225,890
0%
12/31/2017
SSgA Funds Management, Inc.
19,351
0.04%
0
0%
09/06/2018
NH-Amundi Asset Management Co., Ltd.
16,580
0.04%
16,580
0.26%
01/31/2018
BlackRock Advisors (UK) Ltd.
14,817
0.03%
0
0%
09/05/2018
TIAA-CREF Investment Management LLC
13,600
0.03%
0
0%
03/31/2018
Samsung Asset Management Co., Ltd.
11,271
0.03%
-237,163
0.01%
07/06/2018
Bessemer Investment Management LLC
6,025
0.01%
0
0%
04/30/2018
| Address |
Boryung Building
Seoul SL 03127
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.boryung.co.kr |
| Updated |
07/08/2019 |
| Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. |
